DrugPatentWatch Database Preview
« Back to Dashboard
The generic ingredient in REVATIO is sildenafil citrate. There are twenty drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Suppliers and Packaging for NDA: 203109
Profile for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||FOR SUSPENSION;ORAL||Strength||EQ 10MG BASE/ML|
|Approval Date:||Aug 30, 2012||TE:||RLD:||Yes|
Complete Access Available with Subscription